Next-generation immunotherapies for head and neck squamous cell carcinoma: targeting novel immune checkpoints
The eight novel ICs and their integration with emerging biotechnological approaches provide new hope for HNSCC treatment. Further research is needed to clarify the mechanisms of these novel ICs and optimize combination strategies to improve treatment precision and efficacy for HNSCC patients.
Authors
- Jiaqi Tang
- Xinjie Yang (ORCID: https://orcid.org/0000-0002-4537-5303)
- Jianhua Wei
- Huan Li (ORCID: https://orcid.org/0000-0003-2168-3579)
- Yaodong He (ORCID: https://orcid.org/0000-0003-0961-4079)
- Zihui Yang (ORCID: https://orcid.org/0000-0003-1457-5107)
Institutions
- Stomatology Hospital (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1080/07853890.2025.2561223
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09